Jump to content

Definition:Utilization review

From Insurer Brain

🏥 Utilization review is a structured evaluation process used primarily in health and workers' compensation insurance to assess the medical necessity, appropriateness, and efficiency of healthcare services before, during, or after they are delivered to a covered individual. Conducted by clinical professionals — often registered nurses or physicians — working on behalf of an insurer or a third-party utilization review organization, the process aims to ensure that treatment decisions align with evidence-based guidelines and the terms of the insurance policy.

⚙️ The review typically occurs at three stages. Prospective review (prior authorization) evaluates a proposed treatment or admission before it takes place, determining whether the insurer will approve coverage. Concurrent review monitors care while the patient is actively receiving treatment — for example, assessing whether a continued hospital stay remains medically justified. Retrospective review examines claims after services have been rendered, flagging cases where the care delivered may not have met medical-necessity criteria. Each stage relies on clinical protocols, evidence-based guidelines, and insurer-specific coverage policies. When a service is denied, the policyholder or provider can typically pursue an appeals process, and many states mandate external independent review as a final step.

🛡️ Well-executed utilization review serves a dual purpose: it protects the financial integrity of the risk pool by curtailing unnecessary or inappropriate spending, and it safeguards patients by steering care toward proven, effective treatments. For carriers, the process directly influences medical loss ratios, reserve adequacy, and premium competitiveness. However, utilization review also attracts regulatory scrutiny and public criticism when denials are perceived as prioritizing cost containment over patient welfare. State regulators impose strict timelines for review decisions, transparency requirements, and penalties for non-compliance — making the operational design of the review program a matter of both clinical rigor and regulatory strategy.

Related concepts: